Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· Dr. Greg JonesAudio language not provided

Orforglipron Explained: The New Oral GLP-1 for Weight Loss

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

Orforglipron is a new oral GLP-1 medication for weight loss, and many patients are asking how it compares to injectable options like Ozempic, Wegovy, and Zepbound. In this episode, Dr. Greg Jones is joined by Dr. Kris Wusterhausen to explain what orforglipron is, how it works, and where it may fit in the future of medical weight management. They discuss why this oral GLP-1 is different from traditional peptide-based therapies, including how small-molecule medications may affect absorption, dosing convenience, and patient accessibility. The conversation also covers what current research shows about weight-loss results, blood sugar changes, cardiovascular markers, side effects, contraception considerations, surgical precautions, and long-term use. If you are curious about orforglipron, oral GLP-1 medications, weight-loss drugs, metabolic health, muscle preservation, or how these therapies compare with injectable GLP-1 options, this episode offers a practical, clinically informed overview of the benefits, limitations, and unanswered questions. Get 10% off your first order at Dr. Jones Supplement Store when you join the email list. https://drjonessupplements.com/ 📌 About Dr. Kris Wusterhausen Dr. Kris Wusterhausen, DO, is a board-certified Family Medicine physician and founder of The Resurge Clinic in Weatherford, Texas. For nearly two decades, he has focused on hormone optimization, metabolic health, weight management, peptide therapy, and longevity medicine. In addition to caring for patients, Dr. Wusterhausen serves as Medical Director of the BioTE Training Clinic, where he helps educate healthcare providers on advanced approaches to preventive and age-management medicine. He is also a nationally recognized speaker who regularly lectures on hormones, peptides, body composition, and long-term health optimization. 📌Learn More About Dr. Kris Wusterhausen Website: https://www.theresurgeclinic.com/ About Dr. Kris: https://www.theresurgeclinic.com/about/ Facebook: https://www.facebook.com/theresurgeclinic/ YouTube: https://www.youtube.com/playlist?list=PLPZhIf03cd8xu7_CKwAc41vdpeUEQMtem 📌Connect with Dr. Greg Jones Book Dr. Jones to speak at your next event: https://www.drjonesnmd.com/ Enovative Wellness Center: https://enovativewellness.com/ Instagram: https://www.instagram.com/doctorjones_doctorjones/ Facebook: https://www.facebook.com/GregJonesNMD YouTube: https://www.youtube.com/@DrGregJonesNMD Spotify: https://open.spotify.com/show/2QrMGwCIGo1kjdezfCyYDK 🔗 Want to learn more? Check these resources: • FDA Prescribing Information – Foundayo/orforglipron: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf • Lilly – Foundayo/orforglipron FDA Approval Announcement: https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill • Daily oral orforglipron for adults with obesity https://pubmed.ncbi.nlm.nih.gov/37351564/ • Oral orforglipron for type 2 diabetes, HbA1c, and body weight https://pubmed.ncbi.nlm.nih.gov/37369232/ 🔬 Timestamps Introduction and recap of previous episodes (00:00 - 04:27) The evolution of longevity medicine (04:27 - 06:39) Understanding orforglipron as a new molecule (06:39 - 08:08) Bioavailability and absorption: small molecules vs. peptides (08:08 - 13:21) Clinical implications of orforglipron (13:21 - 16:48) Weight loss and patient expectations (16:48 - 20:45) Secondary benefits and cardiovascular health (20:45 - 24:49) Contraception considerations with orforglipron (24:49 - 29:17) Understanding GLP-1 and its implications (29:17 - 30:14) Surgical considerations with GLP-1 medications (30:14 - 33:39) Muscle preservation and management on GLP-1s (33:39 - 40:33) Integrating GLP-1s into hormone optimization protocols (40:33 - 45:30) Cost and accessibility of GLP-1 medications (45:30 - 49:53) Conclusions and future directions for GLP-1s (49:53 - 56:10) Disclaimer: The information shared on The Dr. Jones Optimization Podcast and its associated YouTube channel is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Listening to this podcast or viewing its content does not create a doctor–patient relationship, and nothing shared should be interpreted as individualized medical guidance. Always consult with a qualified healthcare provider before making changes to your health regimen or managing a medical condition. The opinions expressed by Dr. Jones and his guests are their own and do not reflect official medical advice or recommendations.

Dr. Greg Jones · 56 min · Source published: 2026-08-18

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…